Overview of non-Hodgkin's lymphoma: Biology, staging, and treatmentFISHER, Richard I.Seminars in oncology. 2003, Vol 30, Num 2, pp 3-9, issn 0093-7754, 7 p., SUP4Article

Treatment of diffuse large B-cell lymphomasFISHER, Richard I.Seminars in hematology. 2006, Vol 43, Num 4, issn 0037-1963, 66 p.Serial Issue

Immunotherapy in non-Hodgkin's lymphoma: treatment advancesFISHER, Richard I.Seminars in oncology. 2003, Vol 30, Num 2, issn 0093-7754, 50 p., SUP4Serial Issue

Standard treatment of advanced-stage diffuse large B-cell lymphomaCOIFFIER, Bertrand.Seminars in hematology. 2006, Vol 43, Num 4, pp 213-220, issn 0037-1963, 8 p.Article

Novel Therapeutics for Aggressive Non-Hodgkin's LymphomaMAHADEVAN, Daruka; FISHER, Richard I.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1876-1884, issn 0732-183X, 9 p.Article

Toward Better Therapy for Lymphoma and MyelomaFISHER, Richard I; RICHARDSON, Paul G.Journal of clinical oncology. 2011, Vol 29, Num 14, issn 0732-183X, 139 p.Serial Issue

Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-BNADEMANEE, Auayporn; FORMAN, Stephen J.Seminars in hematology. 2006, Vol 43, Num 4, pp 240-250, issn 0037-1963, 11 p.Article

The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomabWAHL, Richard L.Seminars in oncology. 2003, Vol 30, Num 2, pp 31-38, issn 0093-7754, 8 p., SUP4Article

Current therapeutic paradigm for the treatment of non-Hodgkin's lymphomaFISHER, Richard I.Seminars in oncology. 2000, Vol 27, Num 6, pp 2-8, issn 0093-7754, SUP12Conference Paper

Drug resistance in diffuse large B-cell lymphomaWILSON, Wyndham H.Seminars in hematology. 2006, Vol 43, Num 4, pp 230-239, issn 0037-1963, 10 p.Article

New drugs for the treatment of advanced-stage diffuse large cell lymphomasO'CONNO, Owen A; HAMLIN, Paul.Seminars in hematology. 2006, Vol 43, Num 4, pp 251-261, issn 0037-1963, 11 p.Article

Radioimmunotherapy for non-Hodgkin's lymphomas: A historical perspectivePRESS, Oliver W.Seminars in oncology. 2003, Vol 30, Num 2, pp 10-21, issn 0093-7754, 12 p., SUP4Article

A clinical and scientific overview of tositumomab and iodine I 131 tositumomabZELENETZ, Andrew D.Seminars in oncology. 2003, Vol 30, Num 2, pp 22-30, issn 0093-7754, 9 p., SUP4Article

Transformation of Indolent B-Cell LymphomasMONTOTO, Silvia; FITZGIBBON, Jude.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1827-1834, issn 0732-183X, 8 p.Article

Diffuse Large B-Cell LymphomaFRIEDBERG, Jonathan W; FISHER, Richard I.Hematology/oncology clinics of North America. 2008, Vol 22, Num 5, issn 0889-8588, ix, 941-952 [13 p.]Article

The epidemiology of non-Hodgkin's lymphomaFISHER, Susan G; FISHER, Richard I.Oncogene (Basingstoke). 2004, Vol 23, Num 38, pp 6524-6534, issn 0950-9232, 11 p.Article

Role of Functional Imaging in the Management of LymphomaCHESON, Bruce D.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1844-1854, issn 0732-183X, 11 p.Article

The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics PerspectiveSALAVERRIA, Itziar; SIEBERT, Reiner.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1835-1843, issn 0732-183X, 9 p.Article

Allogeneic Transplantation for LymphomaCHAKRAVERTY, Ronjon; MACKINNON, Stephen.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1855-1863, issn 0732-183X, 9 p.Article

Phase 2 Trial of Combined Cisplatin, Etoposide, Gemcitabine, and Methylprednisolone (PEGS) in Peripheral T-Cell Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0350MAHADEVAN, Daruka; UNGER, Joseph M; SPIER, Catherine M et al.Cancer. 2013, Vol 119, Num 2, pp 371-379, issn 0008-543X, 9 p.Article

The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomibDASMAHAPATRA, Girija; PATEL, Hiral; DENT, Paul et al.British journal of haematology. 2013, Vol 161, Num 1, pp 43-56, issn 0007-1048, 14 p.Article

Long-Term Complications of Lymphoma and Its TreatmentNG, Andrea K; LACASCE, Ann; TRAVIS, Lois B et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1885-1892, issn 0732-183X, 8 p.Article

Advances in Imaging and the Management of Myeloma Bone DiseaseTERPOS, Evangelos; MOULOPOULOS, Lia A; DIMOPOULOS, Meletios A et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1907-1915, issn 0732-183X, 9 p.Article

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell LymphomaLENZ, Georg; DAVIS, R. Eric; OTT, German et al.Science (Washington, D.C.). 2008, Vol 319, Num 5870, pp 1676-1679, issn 0036-8075, 4 p.Article

Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma : Southwest Oncology Group Study 0014PERSKY, Daniel O; UNGER, Joseph M; SPIER, Catherine M et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2258-2263, issn 0732-183X, 6 p.Article